Carregant...
Vancomycin use and cytomegalovirus reactivation after allogeneic hematopoietic cell transplantation
Vancomycin exposure in the pre-engraftment period was associated with an increased risk for CMV reactivation after allogeneic HCT. Some gram-positive bacteria may protect against CMV reactivation.
Guardat en:
| Publicat a: | Blood Adv |
|---|---|
| Autors principals: | , , , |
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
American Society of Hematology
2020
|
| Matèries: | |
| Accés en línia: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7322945/ https://ncbi.nlm.nih.gov/pubmed/32556279 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1182/bloodadvances.2020001984 |
| Etiquetes: |
Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|